[TARS] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[TARS] Tarsus Pharmaceuticals, Inc.
Announcement Date
16-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 41.90%
YoY- 11.94%
Quarter Report
TARS's Result
TARS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 1,871 15,277 2,500 10,000 0 15,277 539 129.08%
PBT -40,935 -31,424 -23,419 -13,599 -22,516 -5,743 -20,237 59.87%
Tax -1,787 -27,078 -1,533 -521 -5 519 1 -
NP -39,148 -31,424 -21,886 -13,078 -22,511 -6,262 -20,238 55.18%
Tax Rate - - - - - - - -
Total Cost 41,019 46,701 24,386 23,078 22,511 21,539 20,777 57.30%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -2,092.36 -205.69 -875.44 -130.78 0.00 -40.99 -3,754.73 -32.25%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -1.28 -1.17 -0.82 -0.49 -0.84 -0.26 -0.98 19.46%
EPS Diluted -1.28 -1.17 -0.82 -0.49 -0.84 -0.26 -0.98 19.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.